| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Ocuphire Pharma, Inc. | OCUP | Grant | Common Stock | 11k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | Ocuphire Pharma, Inc. | OCUP | Grant | Stock Option | 9.6k | $3.83 | $36.9k | | 06/06/2023 |
| 05/31/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 9.2k | $26.40 | $244k | | 05/31/2023 |
| 05/31/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 18.5k | $26.21 | $485.5k | | 05/31/2023 |
| 02/14/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 8.5k | $19.96 | $169.7k | | 02/13/2023 |
| 02/13/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 3.3k | $20.42 | $68.1k | | 02/13/2023 |
| 02/06/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 9.4k | $22.22 | $209.5k | | 02/06/2023 |
| 02/06/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 572 | $23.04 | $13.2k | | 02/06/2023 |
| 01/17/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 9.5k | $24.11 | $229.1k | | 01/17/2023 |
| 01/17/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 500 | $24.87 | $12.4k | | 01/17/2023 |
| 01/05/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 9.7k | $21.01 | $203.8k | | 01/05/2023 |
| 01/05/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 300 | $21.46 | $6.4k | | 01/05/2023 |
| 01/04/2023 | Ocuphire Pharma, Inc. | OCUP | Exercise (in-the-money or at-the-money) | Series B Warrant (right to buy) | 1.6k | $0.00 | $0.2 | | 01/04/2023 |
| 11/15/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 11.6k | $22.72 | $263.6k | | 11/15/2022 |
| 11/15/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 900 | $23.48 | $21.1k | | 11/15/2022 |
| 11/08/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 12.4k | $23.56 | $291.5k | | 11/07/2022 |
| 11/07/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 157 | $24.24 | $3.8k | | 11/07/2022 |
| 11/07/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 12.3k | $23.66 | $292.1k | | 11/07/2022 |
| 10/17/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 12.5k | $23.51 | $293.9k | | 10/17/2022 |
| 10/06/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 10k | $22.62 | $226.2k | | 10/05/2022 |
| 10/05/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 7k | $21.92 | $153.5k | | 10/05/2022 |
| 10/05/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 5.5k | $22.83 | $125.5k | | 10/05/2022 |
| 09/16/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 8.9k | $24.38 | $216.2k | | 09/15/2022 |
| 09/16/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 1.1k | $24.99 | $28.3k | | 09/15/2022 |
| 09/15/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 8.4k | $25.10 | $211.5k | | 09/15/2022 |
| 09/15/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 4.1k | $25.59 | $104.2k | | 09/15/2022 |
| 06/13/2022 | Ocuphire Pharma, Inc. | OCUP | Grant | Stock Option (right to buy) | 20k | $1.93 | $38.6k | | 06/13/2022 |
| 05/30/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Stock Option (Right to Buy) | 333.2k | $24.75 | $8.2M | | 05/30/2022 |
| 05/30/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Common Stock | 111.1k | $0.00 | $0 | | 05/30/2022 |
| 04/05/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 4.4k | $49.72 | $217.2k | | 04/05/2022 |
| 04/05/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 3.3k | $50.68 | $169k | | 04/05/2022 |
| 04/05/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 2.2k | $51.59 | $113.3k | | 04/05/2022 |
| 04/05/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 100 | $52.70 | $5.3k | | 04/05/2022 |
| 03/15/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 4.6k | $41.45 | $189.7k | | 03/15/2022 |
| 03/15/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 5.3k | $42.31 | $225.2k | | 03/15/2022 |
|